The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
p53 Family and Cellular Stress Responses in Cancer
Open accessAbstract
p53 is an important tumor suppressor gene, which is stimulated by cellular stress like ionizing radiation, hypoxia, carcinogens, and oxidative stress. Upon activation, p53 leads to cell-cycle arrest and promotes DNA repair or induces apoptosis via several pathways. p63 and p73 are structural homologs of p53 that can act similarly to the protein and also hold functions distinct from p53. Today more than 40 different isoforms of the p53 family members are known. They result from transcription via different promoters and alternative splicing. Some isoforms have carcinogenic properties and mediate resistance to chemotherapy. Therefore, expression patterns of the p53 family genes can offer prognostic information in several malignant tumors. Furthermore, the p53 family constitutes a potential target for cancer therapy. Small molecules (e.g., Nutlins, RITA, PRIMA-1, and MIRA-1 among others) have been objects of intense research interest in recent years. They restore pro-apoptotic wild-type p53 function and were shown to break chemotherapeutic resistance. Due to p53 family interactions small molecules also influence p63 and p73 activity. Thus, the members of the p53 family are key players in the cellular stress response in cancer and are expected to grow in importance as therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–227 of 227
Sosin, A. M., Burger, A. M., Siddiqi, A., Abrams, J., Mohammad, R. M., & Al-Katib, A. M. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-57 · Cited by 40
New insights into oncogenic stress
Haigis, K. M., & Sweet-Cordero, A. (2011) · Nature Genetics · doi:10.1038/ng0311-177 · Cited by 38
Inhibition of v-Abl transformation by p53 and p19ARF
Cong, F., Zou, X., Hinrichs, K., Calame, K. L., & Goff, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203290 · Cited by 38
Ueno, T., Endo, S., Saito, R., Hirose, M., Hirai, S., Suzuki, H., Yamato, K., & Hyodo, I. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13854886566598 · Cited by 36
Schilling, T., Kairat, A., Melino, G., Krammer, P. H., Stremmel, W., Oren, M., & Müller, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.082 · Cited by 36
Self-citationp73 Overexpression and Angiogenesis in Human Colorectal Carcinoma
Guan, M. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg045 · Cited by 35
Botta, G., Proietti‐De‐Santis, L., & Saladino, R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712804143303 · Cited by 35
Downward, J., & Basu, S. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.002 · Cited by 33
Resistance acquisition to MDM2 inhibitors
Cinatl, J., Speidel, D., Hardcastle, I., & Michaelis, M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140035 · Cited by 30
p63 Isoforms Regulate Metabolism of Cancer Stem Cells
D’Aguanno, S., Barcaroli, D., Rossi, C., Zucchelli, M., Ciavardelli, D., Cortese, C., Cola, A. D., Volpe, S., D’Agostino, D., Todaro, M., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr4012574 · Cited by 29
The ARF Tumor Suppressor: Keeping Myc on a Leash
Gregory, M. A., Qi, Y., & Hann, S. R. (2004) · Cell Cycle · doi:10.4161/cc.4.2.1491 · Cited by 29
PCAF is a coactivator for p73-mediated transactivation
Zhao, L., Liu, Y., Bertos, N., Yang, X., & Liao, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206916 · Cited by 28
Cancino, G. I., Miller, F. D., & Kaplan, D. R. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.010 · Cited by 27
Systemic effects of acute cigarette smoke exposure in mice
Itoh, M., Tsuji, T., Nakamura, H., Yamaguchi, K., Fuchikami, J., Takahashi, M., Morozumi, Y., & Aoshiba, K. (2014) · Inhalation Toxicology · doi:10.3109/08958378.2014.917346 · Cited by 27
Erk2 Signaling and Early Embryo Stem Cell Self-Renewal
Meloche, S., Vella, F. D. J., Voisin, L., Ang, S., & Saba-El-Leil, M. K. (2004) · Cell Cycle · doi:10.4161/cc.3.3.674 · Cited by 27
p73 is a p53-independent, Sp1-dependent repressor of cyclin B1 transcription
Innocente, S. A., & Lee, J. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.028 · Cited by 25
Ethayathulla, A. S., Nguyen, H. T., & Viadiu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408039 · Cited by 25
Madka, V., Zhang, Y., Li, Q., Mohammed, A., Sindhwani, P., Lightfoot, S., Wu, X.-R., Kopelovich, L., & Rao, C. V. (2013) · Neoplasia · doi:10.1593/neo.13704 · Cited by 24
Holembowski, L., Schulz‐Heddergott, R., Talos, F., Scheel, A. H., Wolff, S., Dobbelstein, M., & Moll, U. M. (2011) · Cell Cycle · doi:10.4161/cc.10.4.14859 · Cited by 24
Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling
Pishas, K. I., Neuhaus, S. J., Clayer, M., SCHREIBER, A. W., Lawrence, D., Perugini, M., Whitfield, R. J., Farshid, G., Manavis, J., Chryssidis, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2424 · Cited by 24
Family friction as ΔNp73 antagonises p73 and p53
Bailey, S. G., Cragg, M. S., & Townsend, P. A. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.12.022 · Cited by 21
Zou, P., Zheng, N., Yu, Y., Yu, S., Sun, W., McEachem, D., Yang, Y., Yu, L. X., Wang, S., & Sun, D. (2012) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j34s4n · Cited by 15
Prima-1 induces apoptosis in bladder cancer cell lines by activating p53
Piantino, C. B., Reis, S. T., Viana, N. I., da Silva, I. A., Morais, D. R., Antunes, A. A., Dip, N., Srougi, M., & Leite, K. R. M. (2013) · Clinics · doi:10.6061/clinics/2013(03)oa03 · Cited by 15
HuR Is Necessary for Mammary Epithelial Cell Proliferation and Polarity at Least in Part via ΔNp63
Yan, W., Zhang, Y., Zhang, J., Cho, S.-J., & Chen, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045336 · Cited by 12
Díaz, R., González‐Sancho, J. M., Soldevilla, B., Silva, J., García, J. M., García‐Barberán, V., Peña, C., Herrera, M., Gómez, I., Bonilla, F., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20821 · Cited by 9
Non-hominid TP63 lacks retroviral LTRs but contains a novel conserved upstream exon
Beyer, U., & Dobbelstein, M. (2011) · Cell Cycle · doi:10.4161/cc.10.12.15838 · Cited by 5
Expression of the putative tumour suppressor gene,p73, in neuroblastoma and other childhood tumours
Norris, M. D., Gilbert, J., Smith, S. A., Marshall, G. M., Salwen, H. R., Cohn, S. L., & Haber, M. (2001) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(20010101)36:1<48::aid-mpo1013>3.0.co;2-8 · Cited by 3
Cited by
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Pal, A., & Kundu, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03116 · Cited by 597
Major apoptotic mechanisms and genes involved in apoptosis
Kiraz, Y., Adan, A., Kartal Yandim, M., & Baran, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5035-9 · Cited by 582
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
Pajak, B., Siwiak, E., Sołtyka, M., Priebe, A., Zieliński, R., Fokt, I., Ziemniak, M., Jaśkiewicz, A., Borowski, R., Domoradzki, T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010234 · Cited by 574
Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
Liu, G., Pei, F., Yang, F., Li, L., Amin, A., Liu, S., Buchan, J., & Cho, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020367 · Cited by 425
Maier, P., Hartmann, L., Wenz, F., & Herskind, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010102 · Cited by 414
Metadata
- Authors
- Pflaum, J., Schlosser, S., & Müller, M.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2014-10-21
- Volume
- 4
- Pages
- 285-285
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2043157255
- Cited by
- 291
- References
- 227
- FWCI
- 13.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.